Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up

OBJECTIVE: This study was aimed at analyzing the efficacy and safety of an injectable form of chlorogenic acid (CGA) in patients with recurrent high-grade glioma after standard of care treatments, through a first-in-human, open-label, dose-escalation phase I trial. METHODS: A total of 26 eligible pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Zhuang, Li, Shan, Kang, Xun, Deng, Jing, Yang, Huarong, Chen, Feng, Jiang, Jiandong, Zhang, Jie, Li, Wenbin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291982/
https://www.ncbi.nlm.nih.gov/pubmed/37366368
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10291982/
https://www.ncbi.nlm.nih.gov/pubmed/37366368
http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0762

Ejemplares similares